Impulse Dynamics Announces First Patient Enrolled in AIM HIGHer — Implantable Device Trial to Treat Heart Failure in Higher EF Population
March 14, 2022 09:42 ET
|
Impulse Dynamics
MARLTON, N.J., March 14, 2022 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the first...
Deep Drawing Specialist STÜKEN North America Announces First Steps Towards ISO 13485 Certification
March 07, 2022 07:46 ET
|
Stueken, LLC
FOUNTAIN INN, S.C., March 07, 2022 (GLOBE NEWSWIRE) -- Miniaturization and standardization have been driving the rising demand for deep-drawn metal components in the medical industry. STÜKEN North...
IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA
November 01, 2021 08:23 ET
|
Impulse Dynamics
MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first...
IMPULSE DYNAMICS RECEIVES FDA APPROVAL TO MODIFY LABELING FOR OPTIMIZER SMART MEDICAL DEVICES
October 26, 2021 08:57 ET
|
Impulse Dynamics
MARLTON, N.J., Oct. 26, 2021 (GLOBE NEWSWIRE) -- Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure (HF), today announced that the U.S....
Diazyme Laboratories, Inc. Receives Second FDA EUA for COVID-19 Antibody Test
August 17, 2020 20:09 ET
|
General Atomics
SAN DIEGO, Aug. 17, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA test. The Diazyme IgM test runs on...
Diazyme Laboratories, Inc. Announces Partnership for COVID-19 Molecular Diagnostics Test
July 30, 2020 16:06 ET
|
General Atomics
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Diazyme announces partnership with Maccura Biotechnology (USA) LLC, launching a FDA EUA approved SARS-COV-2 RT-PCR diagnostics test. “Here at Diazyme,...
Diazyme Laboratories, Inc. Receives FDA EUA for COVID-19 Antibody Test
July 08, 2020 20:32 ET
|
General Atomics
SAN DIEGO, July 08, 2020 (GLOBE NEWSWIRE) -- Diazyme announces receiving FDA Emergency Use Authorization (EUA) letter for the Diazyme DZ-Lite SARS-CoV-2 IgG CLIA test. The Diazyme IgG test is run on...